The immune system becomes the enemy, attacking the body's own nerve fibers
Sem aviso, o sistema imunitário volta-se contra o próprio corpo — é assim que a esclerose múltipla se instala, destruindo silenciosamente as bainhas protetoras das fibras nervosas e deixando lesões permanentes no sistema nervoso central. Classificada como doença rara, afeta desproporcionalmente as mulheres, numa assimetria que a ciência ainda procura compreender na totalidade. Compreender este padrão não é apenas uma questão académica: é o caminho para diagnósticos mais precoces, intervenções mais eficazes e vidas com maior qualidade.
- O sistema imunitário transforma-se em adversário, atacando as próprias células nervosas e criando lesões que perturbam a visão, a mobilidade, a cognição e a sensibilidade.
- A imprevisibilidade da doença é uma das suas faces mais cruéis — períodos de estabilidade podem ser interrompidos abruptamente por recaídas que alteram tudo.
- As mulheres são diagnosticadas com esclerose múltipla muito mais frequentemente do que os homens, uma disparidade que envolve fatores genéticos, hormonais e imunológicos ainda não totalmente esclarecidos.
- Reconhecer este padrão de género pode acelerar o diagnóstico feminino, abrindo a porta a intervenções mais precoces que travam a progressão da doença.
- Os tratamentos modernos mudaram o horizonte da doença: onde antes havia um caminho linear para a incapacidade, existe hoje a possibilidade de gerir, abrandar e, por vezes, estabilizar a esclerose múltipla durante anos.
A esclerose múltipla chega sem aviso. É uma doença em que o sistema imunitário se volta contra o organismo, atacando as bainhas protetoras das fibras nervosas no cérebro e na medula espinal. O resultado é uma série de lesões no sistema nervoso central — pequenas ruturas no sistema elétrico do corpo — que podem afetar a visão, a mobilidade, a cognição e a sensibilidade, de formas imprevisíveis e variáveis de pessoa para pessoa.
Como acontece com muitas doenças autoimunes, a esclerose múltipla não se distribui de forma uniforme pela população. As mulheres recebem este diagnóstico com muito maior frequência do que os homens. As razões para esta assimetria permanecem parcialmente por explicar — uma combinação de suscetibilidade genética, fatores hormonais e diferenças no funcionamento do sistema imunitário que os investigadores continuam a estudar.
Compreender este padrão tem implicações práticas. Se os clínicos reconhecerem que uma mulher com determinados sintomas neurológicos tem maior probabilidade estatística de ter esclerose múltipla, poderão avançar mais rapidamente para o diagnóstico. E um diagnóstico mais precoce pode significar uma intervenção mais atempada, capaz de abrandar a progressão da doença e reduzir a incapacidade a longo prazo.
As lesões causadas pela esclerose múltipla são permanentes — não desaparecem. Mas os tratamentos modernos transformaram profundamente o que significa viver com esta doença. O objetivo terapêutico é reduzir a frequência e a gravidade das recaídas, limitar a formação de novas lesões e preservar a função neurológica o máximo possível. Em Portugal, como em todo o mundo, milhares de pessoas percorrem este caminho — um caminho longo e individual, mas cada vez menos solitário.
Multiple sclerosis arrives without warning—a disease that turns the body's own immune system into an adversary, attacking the protective sheaths around nerve fibers in the brain and spinal cord. The result is a cascade of lesions across the central nervous system, each one a small rupture in the body's electrical wiring. For those who receive this diagnosis, the path forward becomes uncertain, marked by unpredictable symptoms and the knowledge that their own cells have become the enemy.
Like many autoimmune conditions, multiple sclerosis does not strike randomly across the population. Women receive this diagnosis far more often than men do. The reasons for this disparity remain incompletely understood—a combination of genetic susceptibility, hormonal factors, and immune system differences that researchers continue to unravel. What is clear is that if you are a woman and you develop MS, you are part of a much larger group than if you are a man facing the same disease.
The disease itself is classified as rare, though "rare" carries different weight depending on where you live and what healthcare systems surround you. In Portugal, as elsewhere in Europe, MS represents a significant neurological challenge. The lesions that form in the central nervous system can affect vision, mobility, cognition, and sensation—sometimes all of them, sometimes just one or two. The unpredictability is part of what makes the disease so difficult to live with. A person might experience a period of stability, then suddenly face a relapse that changes everything.
Understanding why women are diagnosed more frequently than men matters not just for epidemiology but for the practical work of early detection and treatment. If clinicians recognize that a woman presenting with certain neurological symptoms is statistically more likely to have MS, they may pursue diagnosis more quickly. Earlier diagnosis can mean earlier intervention, and earlier intervention can slow the disease's progression and reduce long-term disability.
The central nervous system damage that MS causes is permanent. Lesions do not simply disappear. But modern treatments have changed what the disease means for people living with it. Where once MS was a straightforward path toward increasing disability, it is now something that can be managed, slowed, sometimes held in place for years. The goal of treatment is to reduce the frequency and severity of relapses, to minimize new lesion formation, and to preserve as much neurological function as possible for as long as possible.
For anyone navigating a diagnosis of multiple sclerosis, the first steps involve understanding the disease, finding specialists who know how to treat it, and beginning the process of building a treatment plan tailored to their particular form of the disease. The journey is long and individual. But it is no longer a journey taken alone—thousands of people in Portugal and millions worldwide are walking it too, and the medical understanding of how to support them continues to deepen.
The Hearth Conversation Another angle on the story
Why does multiple sclerosis affect women so much more than men? Is it something about female biology that makes the immune system more likely to attack itself?
We don't have a complete answer yet, but yes—biology plays a role. Hormones seem to matter, and there are genetic factors that interact differently in women. But it's not just one thing. It's a combination of how the immune system develops, how it responds to triggers, and possibly environmental factors that affect women differently than men.
If a woman knows she's at higher risk, can she do anything to prevent it?
Not really prevent it, no. But knowing the risk means she and her doctor can watch for early signs. If symptoms appear—vision problems, numbness, fatigue—they can move faster toward diagnosis. And that speed matters. Earlier treatment can change the course of the disease significantly.
What happens to the central nervous system when MS develops? Is the damage reversible?
The immune system attacks the myelin, the insulation around nerve fibers. That creates lesions—scars, essentially. Those scars don't disappear on their own. But modern treatments can stop new lesions from forming and sometimes reduce inflammation enough that some function returns. It's not about cure. It's about slowing the disease and preserving what the person still has.
So someone diagnosed today has a very different prognosis than someone diagnosed twenty years ago?
Completely different. Twenty years ago, MS was often a path toward increasing disability. Now, with the right treatment started early, many people can have long periods where the disease barely progresses. It's still serious, still life-changing. But it's manageable in ways it wasn't before.